Bausch Health Companies | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Amgen USD 2.66B 1.37B 2025-06
ANI Pharmaceuticals USD 15.17M 11.02M 2025-06
Aurora Cannabis CAD 36.22M 38.61M 2024-12
Bausch Health Companies USD 457M 181M 2025-06
Biogen USD 851.8M 540.6M 2025-06
Bristol-Myers Squibb USD 3.77B 366M 2025-06
Canopy Growth CAD -23822000 21.8M 2024-12
Corcept Therapeutics USD 26.67M 23.26M 2025-06
Danaher USD 760M 523M 2025-06
Drreddys Laboratories INR 18.72B 1.17B 2024-12
Eli Lilly USD 7.02B 1.61B 2025-06
Gilead Sciences USD 2.7B 467M 2025-06
Novo Nordisk 34.08B 4.71B 2025-06
Pacira USD 10.23M 8.24M 2025-06
Perrigo USD 55.6M 23.8M 2025-06
Prestige Brands USD 71.76M 16.67M 2025-06
Supernus Pharmaceuticals USD 12.14M 14.74M 2025-06
Vertex Pharmaceuticals USD 1.15B 123.1M 2025-06
Zoetis USD 1.02B 205M 2025-06


Bausch Health Companies Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.